Schneider H P G, Böcker W
Department of Obstetrics & Gynecology, University of Muenster, Germany.
Climacteric. 2006 Apr;9(2):88-107. doi: 10.1080/13697130600677435.
The rudimentary human glandular breast, with the approach of puberty, starts to grow both at glandular and stromal sites. Full differentiation is a gradual process and takes many years, and is only fully attained by pregnancy. The risk of breast cancer is inversely related to parity. Women during adolescence have the highest susceptibility to breast cancer development. This appears to be the period when the mammary gland has the highest number of stem cells. Stem cells may represent important targets for transformational events. Immunohistochemistry allows for identification of the lineage-specific precursor glandular and myoepithelial cells and their differentiated progeny. Both estrogen receptor subtypes are found in epithelial cells of alveoli and ducts as well as in stromal cells. Immunophenotypia of benign proliferative breast disease favors a fundamentally different epithelial composition from that of most malignant epithelial proliferations such as atypical ductal hyperplasia, ductal carcinoma in situ, lobular neoplasia and invasive breast carcinoma. Immunophenotypical characterization of these lesions assists in distinguishing benign from malignant disease. Based on the observation of bilateral risks and frequent multifocality with atypical ductal hyperplasia, atypical lobular hyperplasia and lobular carcinoma in situ, it is suggested that these may represent risk factors as well as precursors. One should, however, realize that ductal as well as lobular premalignant breast lesions ultimately arise from stem cells in the terminal duct lobular units. Estrogen receptor-beta (ERbeta)-positive and ERalpha-negative expression characterizes the highest levels of proliferative cancer cell activity. Point mutations and alterations of co-activators and co-repressors will also determine hormone sensitivity. There is evidence for different genetic pathways in the development of ductal carcinoma in situ and lobular carcinoma in situ. While they share recurrent 16q losses, a second hit in the E-cadherin gene explains the advent of lobular lesions and their common existence with the primary ductal type. Based on our immunocytochemical observations, the most likely target cell of malignant transformation is the Ck18/18-positive and ER-negative transient cell of normal breast epithelium. Pregnancy confers a different genomic imprint to breast epithelial stem cells. Further elucidation of this mechanism may assist in developing appropriate means of breast cancer prevention. This paper is the Pieter van Keep Memorial Lecture given by Professor Hermann Schneider at the 11th World Congress on the Menopause, October 18-22, 2005, in Buenos Aires, Argentina.
人类的原始腺性乳房,随着青春期的临近,开始在腺性和基质部位生长。完全分化是一个渐进的过程,需要数年时间,只有在怀孕时才会完全实现。患乳腺癌的风险与生育次数呈负相关。青春期女性患乳腺癌的易感性最高。这似乎是乳腺干细胞数量最多的时期。干细胞可能是转化事件的重要靶点。免疫组织化学可用于识别谱系特异性的前体腺性细胞和肌上皮细胞及其分化后代。雌激素受体的两种亚型都存在于腺泡和导管的上皮细胞以及基质细胞中。良性增生性乳腺疾病的免疫表型与大多数恶性上皮增生,如非典型导管增生、导管原位癌、小叶瘤变和浸润性乳腺癌,在根本上皮组成上有所不同。这些病变的免疫表型特征有助于区分良性疾病和恶性疾病。基于对双侧风险以及非典型导管增生、非典型小叶增生和小叶原位癌常见多灶性的观察,提示这些可能既是危险因素也是前体病变。然而,应该认识到导管和小叶的乳腺癌前病变最终都起源于终末导管小叶单位中的干细胞。雌激素受体β(ERβ)阳性和雌激素受体α(ERα)阴性表达是增殖性癌细胞活性最高水平的特征。共激活因子和共抑制因子的点突变及改变也将决定激素敏感性。有证据表明导管原位癌和小叶原位癌的发生存在不同的遗传途径。虽然它们都有16号染色体长臂(16q)的反复缺失,但E-钙黏蛋白基因的第二次打击解释了小叶病变的出现以及它们与原发性导管类型的共同存在。基于我们的免疫细胞化学观察,恶性转化最可能的靶细胞是正常乳腺上皮中细胞角蛋白18(Ck18)/18阳性且雌激素受体阴性的瞬时细胞。怀孕赋予乳腺上皮干细胞不同的基因组印记。进一步阐明这一机制可能有助于开发合适的乳腺癌预防方法。本文是赫尔曼·施耐德教授在2005年10月18 - 22日于阿根廷布宜诺斯艾利斯举行的第11届世界绝经大会上发表的彼得·范·凯普纪念讲座。